Facing a denial for colorectal cancer diagnosis insurance benefits after a colonoscopy? In 2026, insurance companies may reject claims due to differing interpretations of pathology reports or undisclosed medical history. This guide explains the common reasons for claim denials and provides actionable solutions for US policyholders navigating Korean health insurance complexities.
Why Are Colorectal Cancer Insurance Claims Denied in Korea?
After a colonoscopy reveals a suspicious polyp, receiving a diagnosis code for malignancy (cancer) typically means you're eligible for insurance payouts. However, insurance companies in Korea may deny these claims, citing their own medical reviews or internal guidelines that conclude the condition doesn't meet their specific policy definition of cancer. This discrepancy often stems from differing interpretations of the pathology report between the treating physician and the insurer's medical advisors. Based on industry experience, these disputes frequently arise from how medical criteria in pathology findings are interpreted against the precise wording and exclusions found within insurance policy terms.
What is 'Breach of Duty to Disclose' and How to Respond?
Another primary reason for claim denial is a 'breach of duty to disclose' (고지의무 위반), meaning you didn't accurately report your medical history when applying for insurance. If you failed to disclose past polyp removals or other relevant treatments during your insurance application, the company can deny your claim or even cancel your policy upon a subsequent cancer diagnosis. It is crucial to provide a complete and truthful account of your health status and past treatments when applying for insurance. Real-world cases show that even minor omissions can escalate into significant disputes, underscoring the importance of full transparency.
Key Clauses to Scrutinize in Your Insurance Policy for Cancer Claims
Resolving disputes over colorectal cancer diagnosis benefits isn't solely about the diagnostic code provided by your doctor. It involves navigating complex and often confusing insurance policy terms, understanding the applicant's medical history, and the insurer's stringent review processes. Pay close attention to the specific pathological criteria defined in your policy for a cancer diagnosis, such as required depth of invasion or evidence of metastasis. Insurers often apply conservative review standards to mitigate financial risk, making a thorough understanding of policy details essential. Because policy interpretations can vary based on individual circumstances, consulting with an expert is highly recommended to ensure your claim is evaluated fairly.
Common Mistakes When Facing Colorectal Cancer Diagnosis Claim Denials
When confronted with a denial for colorectal cancer diagnosis benefits, many policyholders feel lost and unsure how to proceed. A frequent mistake is accepting the insurer's initial denial without further challenge. However, if your primary physician has issued a clear diagnostic code and medical opinion, you have grounds to contest the insurer's subjective judgment. Failing to gather necessary documentation, such as the attending physician's statement and detailed medical records, or misunderstanding the policy's terms can also hinder your case. To prevent these issues, it's advisable to seek assistance from a claims adjusting specialist early on. They can help you prepare a robust case with objective evidence and navigate the complexities of the claims process, protecting your rights against unfair denials stemming from procedural loopholes or differing interpretations.
For more details, check the original source below.
